According to our findings, usenamine A treatment suppressed the proliferation and invasion of human HCC cells, and inhibited ID1 expression by suppressing AKT/mTOR/STAT3 signaling and promoting ubiquitin–proteasome-mediated degradation in HCC cells. Here, STAT3 is linked to hepatocellular carcinoma.